Preference Between The ProSomnus IA And TAP 3 In Bruxers.

Abstract

OBJECTIVES

The purpose of this study is to evaluate the preference of MAD appliances for patients diagnosed with OSA and bruxism using TAP 3 and modified ProSomnus IA oral appliances.

METHODS

Twelve patients diagnosed with OSA were referred for fabrication of a mandibular advancement device (MAD). At the initial appointment each patient was evaluated for signs and symptoms of bruxism. If bruxism was diagnosed the patient was informed of and given the choice to enroll in the research project. Once enrolled and informed consent obtained, digital scans of the patient were acquired using the Primescan (Dentsply Sirona) while in 50-60% of maximum protrusion. The ProSomnus IA was modified to have wings extended 2mm laterally to give similar range of lateral movement as the TAP 3. Patients were randomly chosen for which MAD would be delivered first. One MAD was delivered and used for one month. After one month the patient returned to the clinic and received the alternative MAD. At the final appointment, the patient was asked which device was preferred for long-term treatment.

RESULTS

8 patients enrolled in this study preferred the ProSomnus IA for treatment of OSA over the TAP 3 MAD. One patient was not able to tolerate either device and one dropped out of the study. The two patients who preferred the TAP 3 also used a CPAP simultaneously.

CONCLUSIONS

The modified ProSomnus IA was the preferred device for patients with OSA and bruxism. Patients who used the CPAP and MAD preferred the TAP 3. Patients selected the ProSomnus IA for the following reasons: the ability to open mouth with the IA, increased comfort, and ease of use. The IA was not chosen when the patient also used a CPAP due to discomfort from the wings of the IA on the buccal mucosa when used with a CPAP mask.

IMPLICATIONS

This project compared the preference between the Prosomnus IA and TAP3 appliance in patients that are diagnosed with obstructive sleep apnea and bruxism, potentially improving the decision making for clinicians when treating a patient with OSA and bruxism. Choosing the preferred device first will allow the patient to potentially receive successful treatment for OSA and bruxism in a more timely manner, increasing compliance, saving valuable clinic time, and preventing costly remakes.